Vax-Before-Travel
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Appointments
Destinations
News
Outbreaks
Vaccines
Beyfortus (Nirsevimab) RSV Antibody
Beyfortus (Nirsevimab) RSV Antibody
Fact checked by
Robert Carlson, MD
Jan 5
3 min read
Immunize Infants with Beyfortus As Quickly As Possible
Updated CDC Guidance regarding using Nirsevimab Beyfortus to protect young children from RSV
Respiratory Syncytial Virus (RSV)
Fact checked by
Robert Carlson, MD
Dec 28
3 min read
Infants Protected From RSV Hospitalizations With Passive Immunization
Beyfortus monoclonal antibody found highly effective in protecting infants from severe RSV
Respiratory Syncytial Virus (RSV)
Fact checked by
Robert Carlson, MD
Feb 26
3 min read
Infants May Have Additional Protections Against RSV
RSV monoclonal antibody therapy initially approved in 1998
Respiratory Syncytial Virus (RSV)
Fact checked by
Robert Carlson, MD
Jan 5
4 min read
Single-Dose RSV Protection for Infants Under Review in U.S.
FDA accepts AstraZeneca nirsevimab application
Respiratory Syncytial Virus (RSV)
